Search by Drug Name or NDC
NDC 00121-0670-16 ETHOSUXIMIDE 250 mg/5mL Details
ETHOSUXIMIDE 250 mg/5mL
ETHOSUXIMIDE is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PAI Holdings, LLC. The primary component is ETHOSUXIMIDE.
MedlinePlus Drug Summary
Ethosuximide is used to control absence seizures (petit mal) (a type of seizure in which there is a very short loss of awareness during which the person may stare straight ahead or blink his eyes and does not respond to others). Ethosuximide is in a class of medications called anticonvulsants. It works by reducing abnormal electrical activity in the brain.
Related Packages: 00121-0670-16Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ethosuximide
Product Information
| NDC | 00121-0670 |
|---|---|
| Product ID | 0121-0670_f17f56b2-f448-4fad-8501-1358c24fbfe0 |
| Associated GPIs | 72400010002005 |
| GCN Sequence Number | 004555 |
| GCN Sequence Number Description | ethosuximide SOLUTION 250 MG/5ML ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 17430 |
| HICL Sequence Number | 001891 |
| HICL Sequence Number Description | ETHOSUXIMIDE |
| Brand/Generic | Generic |
| Proprietary Name | ETHOSUXIMIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ETHOSUXIMIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/5mL |
| Substance Name | ETHOSUXIMIDE |
| Labeler Name | PAI Holdings, LLC |
| Pharmaceutical Class | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040253 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00121-0670-16 (00121067016)
| NDC Package Code | 0121-0670-16 |
|---|---|
| Billing NDC | 00121067016 |
| Package | 473 mL in 1 BOTTLE (0121-0670-16) |
| Marketing Start Date | 2000-11-22 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.08855 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | ETHOSUXIMIDE 250 MG/5 ML SOLN |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis